CANCER REGISTRY is an important tool for any successful cancer control program. The first
formal cancer related data from IRAN were published in 1956. In 1969, observations …

Introduction Thyroid cancer (TC) is an important common endocrine malignancy, and its
incidence has increased in the past decades. The current TC diagnosis and classification …

Based on GLOBOCAN 2012, cancers have led to more than 14 million new cases and over
8 million deaths worldwide. The fraction of developing nations is estimated to be 56.9% for …

Thyroid cancer is one of the most common endocrine malignancies, with increasing
incidence all over the world. In spite of good prognosis for differentiated thyroid carcinoma …

Circulating cell‐free DNA (cfDNA) has been considered as a diagnostic source to track
genetic and epigenetic alterations in cancer. We aimed to study mutation in addition to the …

Purpose: Controversies remain over the actual risk of developing a second primary
malignancy (SPM) as a consequence of I-131 treatment in patients with differentiated thyroid …

Thyroid cancer is a frequent endocrine-related malignancy with continuously increasing
incidence, and recently the development in understanding its molecular pathogenesis is …

Transformation of a normal cell to cancerous one is dependent on the accumulation of
several genetic and epigenetic alterations. One of the candidate driver genetic alterations …

Background/Objectives: Thyroid cancer is the most common endocrine malignancy and
accounts for 1% of cancers. In recent years, there has been much interest in the feasibility of …

Purpose Thyroid cancer is recognized as the predominant form of endocrine cancer. The
likelihood of cancer recurrence and the development of distant metastases varies …